HIGH SUSCEPTIBILITY OF U937-DERIVED SUBCLONES TO INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS CORRELATED WITH VIRUS-INDUCED CELL-DIFFERENTIATION AND SUPEROXIDE GENERATION

被引:11
作者
KAMEOKA, M [1 ]
KIMURA, T [1 ]
OKADA, Y [1 ]
NAKAYA, T [1 ]
KISHI, M [1 ]
IKUTA, K [1 ]
机构
[1] HOKKAIDO UNIV,INST IMMUNOL SCI,SEROL SECT,KITA KU,SAPPORO,HOKKAIDO 060,JAPAN
来源
IMMUNOPHARMACOLOGY | 1995年 / 30卷 / 01期
关键词
HIV-1; DIFFERENTIATION; U937; LFA-1; SUPEROXIDE; PHORBOL 12-MYRISTATE 13-ACETATE (PMA);
D O I
10.1016/0162-3109(95)00012-I
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The promonocytic human leukemic cell line U937, when infected with lymphotropic human immunodeficiency virus type 1 (HIV-1), becomes a continuous virus producer. A total of 46 U937-derived subclones in suspension was isolated and classified into three (2 high, 42 middle, and 2 low) types based on their susceptibility to the infection. By analyzing subclones before infection, we found that the high-type subclones expressed LFA-1 antigens at a relatively low level. In addition, the ability of these subclones to induce adherence after exposure to phorbol 12-myristate 13-acetate (PMA) was reduced. In contrast, a transition by HIV-1 infection to adherent macrophage-like cells was induced only in the high-type, but not in the low-type subclones. The high-type adherent cells obtained by HIV-1 infection were followed by further lineage to become retrodifferentiated suspension cells showing reduced syncytia formation ability. Superoxide was generated in the high-type subclones, without PMA-mediated differentiation, from the early stage of infection before HIV-1 replication, as well as during undifferentiated, differentiated and retrodifferentiated stages. In contrast, it was only transiently generated at acute phase of HIV-1 replication in low-type subclones. Long-term culture of the low-type subclones decreased the expression of major structural viral protein Gag and also virus production. Thus, the mechanism by which PMA differentiates U937 cells is not the same as that induced by HIV-1 infection. The latter mechanism results in high susceptibility to infection. The HIV-1 phenotypes of finally obtained persistently infected cells were also affected by the cell stages at the time of infection.
引用
收藏
页码:89 / 101
页数:13
相关论文
共 47 条
  • [31] A DEFECTIVE PROVIRAL DNA WITH A 2.6-KB DELETION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) IN A PERSISTENTLY HIV-1 INFECTED CELL CLONE
    IMAI, H
    MAOTANIIMAI, K
    SHIN, YS
    IKUTA, K
    SUEHIRO, S
    KURIMURA, T
    KATO, S
    HIRAI, K
    VIRUS GENES, 1991, 5 (01) : 81 - 88
  • [32] INTERACTION BETWEEN A MEMBRANE-ASSOCIATED SERINE PROTEINASE OF U-937 MONOCYTES AND PEPTIDES FROM THE V3 LOOP OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) GP120 ENVELOPE GLYCOPROTEIN
    AVRIL, LE
    DIMARTINOFERRER, M
    BARIN, F
    GAUTHIER, F
    FEBS LETTERS, 1993, 317 (1-2) : 167 - 172
  • [33] DETECTION OF TRYPTASE TL(2) AND CD26 ANTIGEN IN BRAIN-DERIVED CELLS NONPERMISSIVE TO T-CELL LINE-TROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SHIMIZU, N
    KOBAYASHI, M
    LIU, HY
    KIDO, H
    HOSHINO, H
    FEBS LETTERS, 1995, 358 (01): : 48 - 52
  • [34] Protein Kinase A Phosphorylation Activates Vpr-Induced Cell Cycle Arrest during Human Immunodeficiency Virus Type 1 Infection
    Barnitz, R. Anthony
    Wan, Fengyi
    Tripuraneni, Vinay
    Bolton, Diane L.
    Lenardo, Michael J.
    JOURNAL OF VIROLOGY, 2010, 84 (13) : 6410 - 6424
  • [35] Human T-cell Leukemia Virus Type-I (HTLV-I) Tax is not the Only One Factor to Enhance Human Immunodeficiency Virus Type-1 (HIV-1) Infection in Culture-supernatants
    Akira Tempaku
    Yosuke Maeda
    Wei Song
    Shinji Harada
    Virus Genes, 2001, 23 : 77 - 80
  • [36] Human T-cell leukemia virus type-I (HTLV-I) tax is not the only one factor to enhance human immunodeficiency virus type-1 (HIV-1) infection in culture-supernatants
    Tempaku, A
    Maeda, Y
    Song, W
    Harada, S
    VIRUS GENES, 2001, 23 (01) : 77 - 80
  • [37] ALTERATION OF DNA TOPOISOMERASE-II ACTIVITY DURING INFECTION OF H9 CELLS BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INVITRO - A TARGET FOR POTENTIAL THERAPEUTIC AGENTS
    MATTHES, E
    LANGEN, P
    BRACHWITZ, H
    SCHRODER, HC
    MAIDHOF, A
    WEILER, BE
    RENNEISEN, K
    MULLER, WEG
    ANTIVIRAL RESEARCH, 1990, 13 (06) : 273 - 286
  • [38] GLYCOSYLATION PATTERNS OF HUMAN IMMUNODEFICIENCY VIRUS - TYPE 1 (HIV-1IIIB) IN HUMAN CELL LINES OF HEMATOPOIETIC ORIGIN (MT-2 AND U937) DIFFERING BY SURFACE RECEPTORS
    Gavazova, Rayna
    Ivanov, Dimitar
    Borissov, Kalin
    Genova-Kalou, Petya
    Raleva, Sevdalina
    Dundarova, Daniela
    Argirova, Radka
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2011, 64 (02): : 231 - 240
  • [39] Pathogenic prion protein fragment (PrP106-126) promotes human immunodeficiency virus type-1 infection in peripheral blood monocyte-derived macrophages
    Bacot, Silvia M.
    Feldman, Gerald M.
    Yamada, Kenneth M.
    Dhawan, Subhash
    VIROLOGY, 2015, 476 : 372 - 376
  • [40] MICROTITER ENZYME-LINKED-IMMUNOSORBENT-ASSAY USING RECOMBINANT-DERIVED ANTIGENS VERSUS WESTERN-BLOT IN THE CONFIRMATION OF PRESENCE OF ANTIBODIES AGAINST THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ROOSENDAAL, R
    VANKAMP, GJ
    MULDER, C
    CALLIAUW, J
    KEMPERS, J
    DIRKS, M
    WOLTERS, EC
    TENKATE, RW
    JOURNAL OF VIROLOGICAL METHODS, 1993, 44 (2-3) : 271 - 280